Avall-Lundqvist E - Search Results

1

Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer.

Hjerpe E, Egyhazi Brage S, Carlson J, Frostvik Stolt M, Schedvins K, Johansson H, Shoshan M, Avall-Lundqvist E. Hjerpe E, et al. BMC Clin Pathol. 2013 Nov 19;13(1):30. doi: 10.1186/1472-6890-13-30. BMC Clin Pathol. 2013. PMID: 24252137 Free PMC article.

2

Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment.

Hernlund E, Hjerpe E, Avall-Lundqvist E, Shoshan M. Hernlund E, et al. Mol Cancer Ther. 2009 Jul;8(7):1916-23. doi: 10.1158/1535-7163.MCT-09-0179. Epub 2009 Jun 30. Mol Cancer Ther. 2009. PMID: 19567816

3

Serum levels of scc, cea, ca-125 and tpa in the management of cervical-carcinoma.

Avalllundqvist E, Schedvins K, Sjovall K, Eneroth P. Avalllundqvist E, et al. Oncol Rep. 1995 Jul;2(4):619-23. doi: 10.3892/or.2.4.619. Oncol Rep. 1995. PMID: 21597788

4

Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.

Wintzell M, Hjerpe E, Åvall Lundqvist E, Shoshan M. Wintzell M, et al. BMC Cancer. 2012 Aug 18;12:359. doi: 10.1186/1471-2407-12-359. BMC Cancer. 2012. PMID: 22901285 Free PMC article.

5

HSP60 predicts survival in advanced serous ovarian cancer.

Hjerpe E, Egyhazi S, Carlson J, Stolt MF, Schedvins K, Johansson H, Shoshan M, Avall-Lundqvist E. Hjerpe E, et al. Int J Gynecol Cancer. 2013 Mar;23(3):448-55. doi: 10.1097/IGC.0b013e318284308b. Int J Gynecol Cancer. 2013. PMID: 23429486

6

Metabolic markers and HSP60 in chemonaive serous solid ovarian cancer versus ascites.

Hjerpe E, Brage SE, Frostvik Stolt M, Johansson H, Shoshan M, Avall-Lundqvist E. Hjerpe E, et al. Int J Gynecol Cancer. 2014 Oct;24(8):1389-94. doi: 10.1097/IGC.0000000000000246. Int J Gynecol Cancer. 2014. PMID: 25188891

7

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist).

Lindemann K, Gibbs E, Åvall-Lundqvist E, dePont Christensen R, Woie K, Kalling M, Auranen A, Grenman S, Hoegberg T, Rosenberg P, Skeie-Jensen T, Hjerpe E, Dørum A, Gebski V, Kristensen G. Lindemann K, et al. Br J Cancer. 2017 Feb 14;116(4):455-463. doi: 10.1038/bjc.2016.435. Epub 2017 Jan 24. Br J Cancer. 2017. PMID: 28118323 Free PMC article. Clinical Trial.

8

Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: A randomised controlled trial.

Salehi S, Åvall-Lundqvist E, Legerstam B, Carlson JW, Falconer H. Salehi S, et al. Eur J Cancer. 2017 Jul;79:81-89. doi: 10.1016/j.ejca.2017.03.038. Epub 2017 Apr 29. Eur J Cancer. 2017. PMID: 28463759 Clinical Trial.

9

Data quality in the Swedish Quality Register of Gynecologic Cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.

Rosenberg P, Kjølhede P, Staf C, Bjurberg M, Borgfeldt C, Dahm-Kähler P, Hellman K, Hjerpe E, Holmberg E, Stålberg K, Tholander B, Åvall Lundqvist E, Högberg T. Rosenberg P, et al. Acta Oncol. 2018 Mar;57(3):346-353. doi: 10.1080/0284186X.2017.1366048. Epub 2017 Aug 22. Acta Oncol. 2018. PMID: 28828920

10

Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a Swedish Gynecologic Cancer Group (SweGCG) study.

Hjerpe E, Staf C, Dahm-Kähler P, Stålberg K, Bjurberg M, Holmberg E, Borgfeldt C, Tholander B, Hellman K, Kjølhede P, Högberg T, Rosenberg P, Åvall-Lundqvist E. Hjerpe E, et al. Acta Oncol. 2018 Mar;57(3):331-337. doi: 10.1080/0284186X.2017.1400691. Epub 2017 Nov 12. Acta Oncol. 2018. PMID: 29130381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page